Kisspeptin alternatives.
4 compounds compared to Kisspeptin, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
Kisspeptin gets attention because of what it does upstream: it is the master regulator of the reproductive neuroendocrine axis, encoded by the KISS1 gene and originally identified as a metastasis suppressor called metastin. It is an endogenous human peptide, not a designer compound. The alternatives search starts at its status: as of 2026 there is no FDA-approved kisspeptin product, human use has occurred under research protocols as an experimental fertility and diagnostic agent, and it is not legally marketed for human treatment. For an approved agent acting on the same axis the options sit further downstream, at HCG, which is approved for specified fertility and endocrine indications.
Kisspeptin is a family of neuropeptides encoded by the KISS1 gene and cleaved from a 145-amino-acid precursor into fragments named for their length (kisspeptin-54, -14, -13, and -10), all sharing a common C-terminal decapeptide that confers biological activity.
- 01HCGS tierFDA-approvedhuman chorionic gonadotropin · Pregnyl
Acts through the gnrh and gonadotropin signalling pathway, like Kisspeptin. FDA-approved.
- 02GonadorelinA tierFDA-approvedGnRH · Factrel
Acts through the gnrh and gonadotropin signalling pathway, like Kisspeptin. FDA-approved.
- 03
- 04
An “alternative” here means a compound that shares Kisspeptin's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.